https://health-fitness.news-articles.net/content/2016/12/08/lilly-presents-neomonarch-phase-2-data-on-abemaciclib-in-early-stage-breast-cancer.html2016-12-08T05:30:00+00:00 https://health-fitness.news-articles.net/content/2016/12/08/lilly-announces-detailed-results-of-solanezumab-phase-3-expedition3-study-at-the-clinical-trials-on-alzheimer-s-disease-ctad.html2016-12-08T18:15:00+00:00 https://health-fitness.news-articles.net/content/2016/12/12/u-s-fda-approves-synjardy-xr-empagliflozin-metformin-hydrochloride-extended-release-tablets-for-adults-with-type-2-diabetes.html2016-12-12T12:28:00+00:00 https://health-fitness.news-articles.net/content/2016/12/15/basaglar-insulin-glargine-injection-100-units-ml-a-long-acting-basal-insulin-is-now-available-in-u-s.html2016-12-15T04:00:00+00:00 https://health-fitness.news-articles.net/content/2016/12/16/chmp-recommends-approval-of-lilly-s-baricitinib-for-the-treatment-of-adults-with-moderate-to-severe-active-rheumatoid-arthritis.html2016-12-16T04:48:00+00:00 https://health-fitness.news-articles.net/content/2016/12/16/boehringer-ingelheim-and-lilly-welcome-new-recommendation-for-jardiance-empagliflozin-tablets-in-updated-american-diabetes-as.html2016-12-16T11:06:00+00:00